RxDoctor Payments Data

Daniel Hay, DO

Family Medicine · Orlando, FLNPI 1578514683

Payments from drug & device makers

$1,219in general payments, 2019–2025

Across 57 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$227
  • Abbott$131
  • Exact Sciences$117
  • Astellas Pharma US Inc$102
  • AbbVie$99
  • Shield Therapeutics Inc$94
  • plus $448 from 10 others

What the payments were for

  • Food & beverage$1,219100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,219 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$6,627
Medicare patients
17
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$35,674
EliquisApixaban14$13,623
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen92$4,630
Testosterone Cypionate24$1,001
Gabapentin55$864
Omeprazole35$839
Oxycodone Hcl49$653
Memantine Hcl ErMemantine Hcl14$634
Methocarbamol21$610
Ibuprofen40$387
Celecoxib15$352
Amlodipine-ValsartanAmlodipine Besylate/Valsartan16$346
Atorvastatin Calcium42$337
Vitamin D2Ergocalciferol (Vitamin D2)16$313
Nifedipine ErNifedipine13$281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$73$35,67415 claims
PfizerEliquis$60$13,62314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →